News and press releases: European Medicines Agency reminds marketing-authorisation holders about revised monographs for human normal immunoglobulin
The European Medicines Agency reminds marketing-authorisation holders of human immunoglobulin-containing medicines that they need to investigate their manufacturing processes to determine if any changes are required to comply with the revised European Pharmacopoeia monograph on human normal immunoglobulin.
Go to Source
